Fibroblast growth factor receptor 1 (FGFR1) variants and craniofacial variation in Amerindians and related populations

被引:9
|
作者
Gomez-Valdes, Jorge A. [2 ]
Huenemeier, Tabita [1 ]
Contini, Veronica [1 ]
Acuna-Alonzo, Victor [3 ,4 ]
Macin, Gaston [3 ]
Ballesteros-Romero, Monica [3 ]
Corral, Pau [5 ]
Ruiz-Linares, Andres [6 ]
Sanchez-Mejorada, Gabriela [2 ]
Canizales-Quinteros, Samuel [2 ,7 ]
Martinez-Abadias, Neus [8 ]
Salzano, Francisco M. [1 ]
Gonzalez-Jose, Rolando [9 ]
Bortolini, Maria Catira [1 ]
机构
[1] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-91501970 Porto Alegre, RS, Brazil
[2] Univ Nacl Autonoma Mexico, Fac Med, Dept Anat, Lab Antropol Fis, Mexico City 04510, DF, Mexico
[3] Escuela Nacl Antropol & Hist, Genet Mol Lab, Mexico City, DF, Mexico
[4] Inst Nacl Med Genom, Mexico City, DF, Mexico
[5] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain
[6] UCL, Dept Genet Evolut & Environm, London, England
[7] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Unidad Biol Mol & Med Genom, Mexico City, DF, Mexico
[8] UPF, CRG, EMBL CRG Syst Biol Res Unit, Barcelona, Spain
[9] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Puerto Madryn, Argentina
关键词
LINKAGE DISEQUILIBRIUM; GENE; EVOLUTION; PRIMATE; SELECTION; PATHWAYS; INSIGHTS; MUTATION; SHAPE; SIZE;
D O I
10.1002/ajhb.22331
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
Objectives: The polymorphic site rs4647905 of the FGFR1 gene was previously associated with a decrease in cephalic index (CI). Here, we evaluate the relationships between genotypes and cephalometric measurements and indices in one Mexican Native and two mestizo Mexican populations using two haplotype-tag SNPs (rs4647905 and rs3213849) that represent >85% of the FGFR1 variability, plus three other SNPs (rs2293971, rs2304000, and rs930828) situated nearby. In addition, we genotyped five South American natives, two European, one African, and one Siberian populations to evaluate their intra and intercontinental population diversity. Methods: The five SNPs were tested and the craniofacial measurements and indices were collected using standardized procedures. Principal Component Analysis was used to verify individual/population comparisons. Associations were performed through the generalized linear model (GLM), coefficient of determination R2 and linear regression tests. Results: We found a tendency for a decrease in CI in individuals homozygous for allele rs4647905C, regardless of the population to which they belong, though the effect is more pronounced in mestizo. When the GLM analyses were performed using the absolute/linear cephalometric measurements, a statistically significant association was found between four SNPs and head length in the mestizo population. Conclusions: FGFR1 polymorphisms, especially rs4647905, can have an important role in the normal human skull variation, primarily due to their influence in head length, which would affect other cephalometric absolute/linear measures as well as indices like CI as a result of the pervasive nature of the morphological integration that characterizes the human skull. Am. J. Hum. Biol. 2013. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:12 / 19
页数:8
相关论文
共 50 条
  • [21] Exploring The Role of Digital Pathology in Analysis of Fibroblast Growth Factor Receptor 1 (FGFR1) Profile in Liver Disease
    Imawana, R.
    Clegg, F.
    Thompson, D.
    McLean, M.
    Delibegovic, M.
    Murray, G.
    JOURNAL OF PATHOLOGY, 2023, 261 (SUPPL1): : S40 - S40
  • [22] 90-kDa ribosomal S6 kinase is a direct target for the nuclear fibroblast growth factor receptor 1 (FGFR1) - Role in FGFR1 signaling
    Hu, YF
    Fang, XH
    Dunham, SM
    Prada, C
    Stachowiak, EK
    Stachowiak, MK
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (28) : 29325 - 29335
  • [23] An unusual FGFR1 mutation (fibroblast growth factor receptor 1 mutation) in a girl with non-syndromic trigonocephaly
    Kress, W
    Petersen, B
    Collmann, H
    Grimm, T
    CYTOGENETICS AND CELL GENETICS, 2000, 91 (1-4): : 138 - 140
  • [24] Global Developmental Gene Programing Involves a Nuclear Form of Fibroblast Growth Factor Receptor-1 (FGFR1)
    Terranova, Christopher
    Narla, Sridhar T.
    Lee, Yu-Wei
    Bard, Jonathan
    Parikh, Abhirath
    Stachowiak, Ewa K.
    Tzanakakis, Emmanuel S.
    Buck, Michael J.
    Birkaya, Barbara
    Stachowiak, Michal K.
    PLOS ONE, 2015, 10 (04):
  • [25] Calcium Signaling in GABAergic-Cortical Astrocyte coCulture is influenced by Fibroblast Growth Factor Receptor 1 (FGFR1)
    Rogers, D. J.
    Hendrick, M.
    Watson, G. M.
    Smith, K. M.
    INTEGRATIVE AND COMPARATIVE BIOLOGY, 2017, 57 : E143 - E143
  • [26] New intronic Fibroblast Growth Factor Receptor 1 (FGFR1) mutation leading to disrupted splicing and Kallmann syndrome
    Kansakoski, J.
    Vaaralahti, K.
    Raivio, T.
    HUMAN REPRODUCTION, 2018, 33 (02) : 328 - 330
  • [27] Fibroblast growth factor receptor 1 (FGFR1) expression and activation in clear cell renal cell carcinoma (ccRCC).
    Ho, T. H.
    Wang, F.
    Hoang, A.
    Tamboli, P.
    Jonasch, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [28] Fibroblast Growth Factor Receptor-1 (FGFR1) Nuclear Dynamics Reveal a Novel Mechanism in Transcription Control
    Dunham-Ems, Star M.
    Lee, Yu-Wei
    Stachowiak, Ewa K.
    Pudavar, Haridas
    Claus, Peter
    Prasad, Paras N.
    Stachowiak, Michal K.
    MOLECULAR BIOLOGY OF THE CELL, 2009, 20 (09) : 2401 - 2412
  • [29] Concordance in fibroblast growth factor receptor 1 (FGFR1) and 2 (FGFR2) status in breast cancer during tumor progression
    Zamora, E.
    Aura, C.
    Perez-Garcia, J.
    Prudkin, L.
    Meire, A.
    Munoz Cosuelo, E.
    Jimenez, J.
    Diaz-Delgado, M.
    Ortega, V.
    Soberino, J.
    Farinas, L.
    Salva, F.
    Bellet, M.
    Cruz, C.
    Gomez, P.
    Oliveira, M.
    Vidal, M. J.
    Saura, C.
    Cortes, J.
    Nuciforo, P.
    CANCER RESEARCH, 2016, 76
  • [30] Tinengotinib, a novel fibroblast growth factor receptor (FGFR) inhibitor, is potent against resistance mutations in FGFR1/2/3
    Qiang, Xiaoyan
    Yu, Qi
    Fan, Jean
    Wu, Frank
    Sun, Caixia
    Peng, Peng
    CANCER RESEARCH, 2023, 83 (08)